The goal of this presented protocol is to share optimized surgical experience for establishing a non-arterialized rat liver transplantation model, specifically focusing on technical refinements that ensure long-term animal survival beyond 100 days.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
* These authors contributed equally
The goal of this presented protocol is to share optimized surgical experience for establishing a non-arterialized rat liver transplantation model, specifically focusing on technical refinements that ensure long-term animal survival beyond 100 days.
In experimental liver transplantation, the rat model is the gold standard for investigating transplant immunology and metabolic processes; however, reconstructing the exceedingly fine hepatic artery (~0.5 mm) presents a formidable technical challenge. To circumvent this, the simplified non-arterialized rat liver transplantation (NArLT) model is widely utilized. Unfortunately, severe biliary complications—such as bile leakage and ischemic cholangitis—arising from arterial deprivation frequently restrict the long-term survival of recipients. This obstacle significantly limits research on key topics, including long-term host-graft immunocompatibility and chronic rejection. Herein, we present an optimized protocol for the NArLT model that incorporates critical technical refinements to successfully overcome these ischemic biliary injuries. Key improvements include a significantly shortened anhepatic phase, a “no-touch” biliary dissection technique, thorough biliary tract flushing, and an optimized internal biliary stenting method. After implementing this improved procedure, the recipient survival rate exceeded 94% during the 100-day observation period. Ultimately, this optimized protocol provides a highly reproducible and robust platform to investigate the mechanisms underlying long-term transplant tolerance, thereby supporting the development of novel therapeutic strategies in transplantation medicine.
The rat liver transplantation model serves as the most widely utilized experimental platform for basic transplant research. However, its broader application is frequently hindered by a notoriously steep learning curve, which can significantly impede the progress of downstream experimental studies1,2. Furthermore, conventional rat liver transplantation models often suffer from suboptimal surgical success and low long-term survival rates. By critically streamlining the surgical procedures, meticulously refining operative details, and performing vascular and biliary reconstructions under direct visualization, the....
Access restricted. Please log in or start a trial to view this content.
All animal experiments and surgeries in this study were approved by the Experimental Animal Ethics Committee of Qingdao University (No. 20260301SD5020260401065). Make all efforts to minimize animal suffering.
1. Preoperative Preparation
Access restricted. Please log in or start a trial to view this content.
To ensure consistent surgical quality and reproducibility across the NArLT models, all procedures were performed by the same experienced microsurgeon. A total of 50 rat liver transplantations were completed during the study period. The mean durations for the surgical procedures were as follows: donor surgery averaged 25.3 ± 2.6 min, ex vivo graft preparation averaged 13.1 ± 2.1 min, recipient surgery averaged 43.0 ± 1.6 min, and the anhepatic phase averaged 15.7 ± 1.2 min.
Recipients undergoin.......
Access restricted. Please log in or start a trial to view this content.
The NArLT model is a cornerstone for experimental transplant research due to its avoidance of complex microvascular arterial anastomosis11. However, conventional NArLT methods are historically plagued by high rates of biliary complications—up to 30%—which severely limit long-term survival and hinder chronic immunological studies2. The significance of the proposed method lies in its ability to circumvent these ischemic biliary injuries. In this study, the 100-day.......
Access restricted. Please log in or start a trial to view this content.
The authors declare no conflicts of interest.
This work was supported by the National Natural Science Foundation of China (No.82370666), Key R&D Program of Shandong Province, China (No.2025KJHZ016) and Fujian provincial health technology project (No. 2023CXA014).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 4-0 Absorbable Suture | Ethicon | W9109H | Used for closure of musculofascial layer (linea alba) |
| 4-0 Silk Suture | Ethicon | VCP304H | Used for skin closure |
| 7-0 or 8-0 Suture / Silk Tie | Ethicon | Z1711E | Used for ligation of vessels (e.g., left phrenic vein) |
| 22G Intravenous Catheter | B. Braun | 4252098B | Trimmed to 5–7 mm with inclined ends to prepare biliary stent |
| 23G Scalp Vein Needle | Shandong Qinkai Medical Industry Co., Ltd. | MDLSSVS | Used for insertion into abdominal aorta for liver perfusion |
| Buprenorphine | Tianjin Institute of Pharmaceutical Research Pharmaceutical Co., Ltd. | H12020275 | Administered as subcutaneous analgesia post-surgery |
| Cotton Swab | Aoocn | 216-236 | Used to gently elevate liver during dissection |
| Crushed Ice | N/A | N/A | Used to maintain graft temperature during ex vivo preparation |
| Elastic Retractors | N/A | N/A | Used to retract abdominal wall during laparotomy |
| Epidural Catheter Sheaths | Jiangsu Maichuang Medical Device Co., Ltd. | 20173084015 | Sizes 5F and 6F; used as cuffs for PV and IHIVC |
| Gauze | Central Medical Technology Co., Ltd. | CH-1001 | Saline-soaked; used to cover and protect intestines |
| Glucose Solution (5%) | Sichuan Kelun Pharmaceutical Co., Ltd. | H20044307 | Used to flush intrahepatic blood during recipient hepatectomy |
| Heparin Saline | Shenzhen Life Biotechnology Co., Ltd. | H2012003 | 100 IU/mL; used to soak biliary stent |
| Indwelling Needle | B. Braun | 4254074B | Used to flush SHIVC to remove air before completing anastomosis |
| Isoflurane | Jinan Guangshengyuan Biotechnology Co., Ltd. | 153107015 | 5% concentration; used for anesthesia induction |
| Microvascular Clamps | Shanghai Medical Devices Co., Ltd. | JCZ200 | Used for vessel occlusion during surgery |
| Mosquito Forceps | Shanghai Medical Devices Co., Ltd. | J31010 | Used for fine manipulation and cuff preparation |
| Normal Saline (0.9%) | Sichuan Kelun Pharmaceutical Co., Ltd. | H20044304 | Used for irrigation and gauze soaking (37°C) |
| Pentobarbital (1%) | Shanghai Yuansi Technology Co., Ltd. | P0500000 | 40–45 mg/kg; used for surgical anesthesia |
| Peripherally Inserted Venous Catheter (PIVC) | Covidien | 8888145015 | Used to flush cuffed PV and confirm patency |
| Povidone-Iodine | Shanxi Trinda Biotechnology Co., Ltd. | 41836054 | Used for surgical site disinfection |
| Rubber Band (from Surgical Glove) | Ansell | N/A | Used for SHIVC traction during recipient surgery |
| Sprague–Dawley Rats | Huafukang (Beijing) Biotechnology Co., Ltd. | 22001A | Adult male rats, 8–10 weeks, 220–250 g |
| Sterile Petri Dish (10 cm) | Shandong Enyou Biotechnology Co., Ltd. | H905001 | Used to hold graft in UW solution during ex vivo preparation |
| Syringe (20 mL) | Shandong Weigao Group Medical Polymer Products Co., Ltd. | 20163141593 | Used for controlled liver perfusion (3–3.5 mL/min) |
| UW Preservation Solution | Bridge to Life | BTL-UW-1L | Maintained at 4°C; used for donor liver perfusion and graft preservation |
Access restricted. Please log in or start a trial to view this content.
